drugset / Trial / NCT00097045

Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C

NCT00097045 ↗

Phase 2 Completed 90 enrolled Intarcia Therapeutics
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to compare the safety, tolerability and antiviral effects of omega interferon administered alone to omega interferon administered with ribavirin in the treatment of subjects with chronic Hepatitis C virus (HCV) infection.

Timeline

Start
2004-11
Primary completion
—
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ribavirin Small molecule — —
Subject omega interferon Unknown — Subcutaneous